A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

The FDA and CDC recommend getting the new COVID vaccine to fight the new variants spreading this fall. Florida Surgeon ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

This guide will walk you through how to get the updated COVID-19 vaccine for free in NYC, even if you are undocumented or ...

A growing number of U.S. adults are hesitant to get recommended vaccines this fall, a new survey found. Doctors discuss ...

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 ...

1 strain of the virus. "Today's authorization provides an additional COVID-19 vaccine option," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. Doses are on ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

Valneva SE (VALN) said that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to ...

Valneva expects to submit data to the U.S. Food and Drug Administration (FDA) this year to also support potential label extensions in the U.S. IXCHIQ ® is the world’s first and only licensed ...